Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

IDEAYA Biosciences (IDYA) EBIAT (2019 - 2025)

IDEAYA Biosciences' EBIAT history spans 7 years, with the latest figure at -$83.3 million for Q4 2025.

  • For Q4 2025, EBIAT rose 36.1% year-over-year to -$83.3 million; the TTM value through Dec 2025 reached -$113.7 million, up 58.58%, while the annual FY2025 figure was -$113.7 million, 58.58% up from the prior year.
  • EBIAT for Q4 2025 was -$83.3 million at IDEAYA Biosciences, down from $119.2 million in the prior quarter.
  • Across five years, EBIAT topped out at $119.2 million in Q3 2025 and bottomed at -$130.3 million in Q4 2024.
  • The 5-year median for EBIAT is -$25.8 million (2022), against an average of -$30.5 million.
  • The largest annual shift saw EBIAT crashed 1799.07% in 2023 before it surged 330.11% in 2025.
  • A 5-year view of EBIAT shows it stood at -$18.2 million in 2021, then plummeted by 32.88% to -$24.2 million in 2022, then plummeted by 40.3% to -$34.0 million in 2023, then tumbled by 283.78% to -$130.3 million in 2024, then surged by 36.1% to -$83.3 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's EBIAT are -$83.3 million (Q4 2025), $119.2 million (Q3 2025), and -$77.5 million (Q2 2025).